Gufic Biosciences Profit & Loss Annual

BSE: 509079 | NSE: GUFICBIO | ISIN: INE742B01025 | Sector: Biotechnology & Drugs

416.05 +12.90 (3.20%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	806.67	690.62	779.16	487.70
Total Revenue	806.67	690.62	779.16	487.70
Costof Revenue Total	389.90	364.27	441.60	272.21
Gross Profit	416.77	326.35	337.56	215.49
Selling/ General/ Admin Expenses Total	109.63	178.99	169.97	117.16
Depreciation/ Amortization	17.02	22.28	17.13	16.29
Other Operating Expenses Total	161.27	4.60	17.44	12.29
Total Operating Expense	677.81	575.29	650.57	420.07
Operating Income	128.85	115.33	128.58	67.63
Interest Inc( Exp) Net- Non- Op Total	-153.60	-81.84	-9.14	-88.81
Other Net	2.18	-0.46	-0.90	-1.08
Net Income Before Taxes	115.67	106.72	126.84	57.71
Provisionfor Income Taxes	29.54	27.02	31.00	13.48
Net Income After Taxes	86.14	79.70	95.84	44.23
Net Income Before Extra Items	86.14	79.70	95.84	44.23
Net Income	86.14	79.70	95.84	44.23
Income Availableto Com Excl Extra Ord	86.14	79.70	95.84	44.23
Income Availableto Com Incl Extra Ord	86.14	79.70	95.84	44.23
Diluted Net Income	86.14	79.70	95.84	44.23
Diluted Weighted Average Shares	9.86	9.69	9.69	9.69
Diluted EPS Excluding Extra Ord Items	8.74	8.22	9.89	4.56
DPS- Common Stock Primary Issue	0.10	0.10	-	0.10
Diluted Normalized EPS	8.74	8.22	9.88	4.56
Research Development	-	51.56	44.29	20.99
Gain( Loss)on Saleof Assets	-	0.30	0.68	0.37
Unusual Expense( Income)	-	-	0.00	0.02